A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
This study evaluates the safety and effectiveness of an investigational study drug (called CTP-543) in adults (18 years and older) who have 50% or greater scalp hair loss.
Inclusion Criteria:
Exclusion Criteria:
Fort Gratiot, Michigan 48059, United States
New York, New York 10032, United States
Nice, Alpes-maritimes 06202 CEDEX 3, France
Frankfurt am Main, Hesse 60590, Germany
Berlin, 10117, Germany
Pécs, Baranya 7632, Hungary
Szeged, Csongrád-csanád 6720, Hungary
Budapest, Pest County 1085, Hungary